Metraipolis › archive › dc_30a7f484dd0e

Healthcare provider approaches to managing the health harms of xylazine: A qualitative study — Europe PMC PMID:42276321

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42276321
DOI
10.1016/j.josat.2026.210051
License (as archived)
solo-consultazione
Archived
2026-10-31T14:10:27.221Z
SHA-256 of the archived text
2c2364dc6116cf2037757880ff385bad6a04edf4d8e32b691630bc2909655205
Stable URL of this page
https://metraipolis.com/documento/dc_30a7f484dd0e

How to cite

Healthcare provider approaches to managing the health harms of xylazine: A qualitative study — Europe PMC PMID:42276321 — Europe PMC (en), https://europepmc.org/article/MED/42276321 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_30a7f484dd0e (Metraipolis archive dc_30a7f484dd0e, sha256 2c2364dc6116cf2037757880ff385bad6a04edf4d8e32b691630bc2909655205)
BibTeX
@misc{dc30a7f484dd0e,
  title = {Healthcare provider approaches to managing the health harms of xylazine: A qualitative study — Europe PMC PMID:42276321},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42276321},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_30a7f484dd0e; sha256 2c2364dc6116cf2037757880ff385bad6a04edf4d8e32b691630bc2909655205},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42276321. Agents can read the archived copy with the MCP tool read_document.